Receptores tipo Toll: entre el reconocimiento de lo

INMUNOLOGÍA M. MESA-VILLANUEVA, P.J. PATIÑO
51. Duits LA, Nibbering PH, van Strijen E, Vos JB, Mannesse-Lazeroms
SP, van Sterkenburg MA, et al. Rhinovirus increases human betadefensin-2
and -3 mRNA expression in cultured bronchial epithelial
cells. FEMS Immunol Med Microbiol 2003; 38: 59-64.
52. Cario E, Rosenberg IM, Brandwein SL, Beck PL, Reinecker HC,
Podolsky DK. Lipopolysaccharide activates distinct signaling
pathways in intestinal epithelial cell lines expressing Toll-like
receptors. J Immunol 2000; 164: 966-972.
53. Abreu MT, Vora P, Faure E, Thomas LS, Arnold ET, Arditi M.
Decreased expression of Toll-like receptor-4 and MD-2 correlates
with intestinal epithelial cell protection against dysregulated
proinflammatory gene expression in response to bacterial
lipopolysaccharide. J Immunol 2001; 167: 1609-1616.
54. Abreu MT, Arnold ET, Thomas LS, Gonsky R, Zhou Y, Hu B, et
al. TLR4 and MD-2 expression is regulated by immune-mediated
signals in human intestinal epithelial cells. J Biol Chem 2002; 277:
20431-20437.
55. Ortega-Cava CF, Ishihara S, Rumi MA, Aziz MM, Kazumori H,
Yuki T, et al. Strategic compartmentalization of Toll-like receptor
4 in the mouse gut. J Immunol 2003; 170: 3977-3985.
56. Hornef MW, Frisan T, Vandewalle A, Normark S, Richter-Dahlfors
A. Toll-like receptor 4 resides in the Golgi apparatus and colocalizes
with internalized lipopolysaccharide in intestinal epithelial cells.
J Exp Med 2002; 195: 559-570.
57. Arron JR, Choi Y. Bone versus immune system. Nature 2000; 408:
535-536.
58. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and
activation. Nature 2003; 423: 337-342.
59. Nair SP, Meghji S, Wilson M, Reddi K, White P, Henderson B.
Bacterially induced bone destruction: mechanisms and
misconceptions. Infect Immun 1996; 64: 2371-2380.
60. Asai Y, Hirokawa Y, Niwa K, Ogawa T. Osteoclast differentiation
by human osteoblastic cell line SaOS-2 primed with bacterial lipid
A. FEMS Immunol Med Microbiol 2003; 38: 71-79.
61. Bi Y, Seabold JM, Kaar SG, Ragab AA, Golberg VM, Andreson
JM, et al. Adherent endotoxin on orthopedic wear particles stimulates
cytokine production and osteoclast differentiation. J Bone Miner
Res 2001; 16: 2082-2091.
62. Gasper NA, Petty CC, Schrum LW, Marriott I, Bost KL. Bacteriuminduced
CXCL10 secretion by osteoblasts can be mediated in
part through toll-like receptor 4. Infect Immun 2002; 70: 4075-
4082.
63. Kondo A, Koshihara Y, Togari A. Signal transduction system for
interleukin-6 synthesis stimulated by lipopolysaccharide in human
osteoblasts. J Interferon Cytokine Res 2001; 21: 943-950.
64. Sato N, Takahashi N, Suda K, Nakamura M, Yamaki M, Ninomiya
T, Kobayashi Y, et al. MyD88 but not TRIF is essential for
osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide,
and IL-1alpha. J Exp Med 2004; 200: 601-611.
65. Lacroix S, Feinstein D, Rivest S. The bacterial endotoxin
lipopolysaccharide has the ability to target the brain in upregulating
its membrane CD14 receptor within specific cellular populations.
Brain Pathol 1998; 8: 625-640.
66. Laflamme N, Rivest S. Toll-like receptor 4: the missing link of the
cerebral innate immune response triggered by circulating gramnegative
bacterial cell wall components. FASEB J 2001; 15: 155-
163.
67. Laflamme N, Soucy G, Rivest S. Circulating cell wall components
derived from gram-negative, not gram-positive, bacteria cause a
profound induction of the gene-encoding Toll-like receptor 2 in
the CNS. J Neurochem 2001; 79: 648-657.
68. Bsibsi M, Ravid R, Gveric D, van Noort JM. Broad expression of
Toll-like receptors in the human central nervous system. J Neuropathol
Exp Neurol 2002; 61: 1013-1021.
69. Netea MG, Kullberg BJ, Van der Meer JW. Circulating cytokines
as mediators of fever. Clin Infect Dis 2000; 31(Suppl 5): S178-S184.
70. Brochu S, Olivier M, Rivest S. Neuronal activity and transcription
of proinflammatory cytokines, IkappaBalpha, and iNOS in the
mouse brain during acute endotoxemia and chronic infection with
Trypanosoma brucei brucei. J Neurosci Res 1999; 57: 801-816.
71. Nguyen MD, Julien JP, Rivest S. Innate immunity: the missing
link in neuroprotection and neurodegeneration? Nat Rev Neurosci
2002; 3: 216-227.
72. Dantzer R, Wollman EE. [Relationships between the brain and
the immune system]. J Soc Biol 2003; 197: 81-88.
73. Ohashi K, Burkart V, Flohe S, Kolb H. Cutting edge: heat shock
protein 60 is a putative endogenous ligand of the toll-like receptor-
4 complex. J Immunol 2000; 164: 558-561.
74. Vabulas RM, Ahmad-Nejad P, da Costa C, Miethke T, Kirschning
CJ, Hacker H, et al. Endocytosed HSP60s use toll-like receptor
2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor
signaling pathway in innate immune cells. J Biol Chem 2001;
276: 31332-31339.
75. Habich C, Baumgart K, Kolb H, Burkart V. The receptor for heat
shock protein 60 on macrophages is saturable, specific, and distinct
from receptors for other heat shock proteins. J Immunol 2002; 168:
569-576.
76. Vabulas RM, Ahmad-Nejad P, Ghose S, Kirschning CJ, Issels
RD, Wagner H. HSP70 as endogenous stimulus of the Toll/
interleukin-1 receptor signal pathway. J Biol Chem 2002; 277:
15107-15112.
77. Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC,
Gallo RL. Hyaluronan fragments stimulate endothelial recognition
of injury through TLR4. J Biol Chem 2004; 279: 17079-17084.
78. Guillot L, Balloy V, McCormack FX, Golenbock DT, Chignard M,
Si-Tahar M. Cutting edge: the immunostimulatory activity of the
lung surfactant protein-A involves Toll-like receptor 4. J Immunol
2002; 168: 5989-5992.
129